| Kroger Pharmacy L-362 | |
| 111 Towne Dr, Elizabethtown, Kentucky 42701 | |
| (270) 737-1710 |
| Name | Kroger Pharmacy L-362 |
|---|---|
| Organization Name | Kroger Limited Partnership I |
| Location | 111 Towne Dr, Elizabethtown, Kentucky 42701 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (270) 737-1710 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed enrollment of the first 40 subject cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 2 days ago
| NPI Number | 1750315578 |
| Organization Name | KROGER LIMITED PARTNERSHIP I |
| Doing Business As | KROGER PHARMACY |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 111 Towne Dr, Elizabethtown, KY 42701 |
| Phone Number | 270-737-1710 |
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed enrollment of the first 40 subject cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 2 days ago
News Archive
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed enrollment of the first 40 subject cohort in the dose-ranging Phase II study of ADXS-HPV, an immunotherapy for Cervical Intraepithelial Neoplasia.
Researchers from the University of California, San Diego recently offered the sharpest-yet picture of how core biochemical pathways in skeletal muscle cells and fat cells are altered in people who suffer from insulin resistance-a primary defect in type 2 diabetes and obesity. Taking a systems biology approach, the bioengineers and medical researchers also determined how a common class of drugs for treating insulin resistance-TZDs-alter these same core pathways.
The most common neurological diseases cost the United States $789 billion in 2014, and this figure is projected to grow as the elderly population doubles between 2011 and 2050, according to a new study published in the April issue of the Annals of Neurology.
With the first U.S. implant of its new Activa SC neurostimulator for deep brain stimulation therapy, Medtronic, Inc. today announced the technology's commercial availability throughout the United States and Europe.
› Verified 2 days ago
Apothecare Pharmacy Type: Pharmacy Location: 1239 Woodland Dr, Elizabethtown, Kentucky 42701 Phone: (270) 739-0303 | |
Apothecare Pharmacy Of Elizabethtow Type: Pharmacy Location: 1028 N Dixie Ave, Elizabethtown, Kentucky 42701 Phone: (270) 982-0303 | |
Hanger Clinic Type: Durable Medical Equipment & Medical Supplies Supplier Location: 105 Financial Pl, Elizabethtown, Kentucky 42701 Phone: (270) 737-2672 | |
20/20 Eye Care Type: Medicare Supplier Location: 1709 N Dixie Ave, Elizabethtown, Kentucky 42701 Phone: (270) 765-2020 | |
Visionworks Doctors Of Optometry Type: Eyewear Supplier (Equipment, not the service) Location: 1609 N Dixie Ave, Elizabethtown, Kentucky 42701 Phone: (270) 765-7372 |